AT&T's stock rebounds, HCA and P&G shares head higher after earnings, and more stock movers
By Barbara Kollmeyer and Emily Bary
BuzzFeed shares extend their decline
Here are some of the biggest stock movers on Friday as U.S. stock indexes headed slightly lower.
Stocks gaining:
HCA Healthcare Inc.'s stock (HCA) was jumping 6% after the hospital operator reported a forecast-beating profit and lifted its full-year outlook, benefiting from increased emergency-room visits, surgeries and admissions.
AT&T Inc.'s stock (T) was rallying more than 3% in afternoon trading, a day after suffering its second-worst percentage decline on record. HSBC upgraded the telecommunications name.
Procter & Gamble Co.'s stock (PG) was rising nearly 4% after the consumer goods giant's fiscal third-quarter results topped Wall Street top-line and bottom-line estimates, and the company lifted its full-year sales outlook. P&G benefited from pricing moves.
Tesla Inc. shares (TSLA) were up 1.5% in afternoon trading after the electric vehicle maker raised prices on some models. Shares had tumbled nearly 10% in Thursday's session. The move came after CEO Elon Musk suggested Wednesday he would give priority to market share over margins, a stance that surprised some on Wall Street. Truist Securities on Friday became the latest on Wall Street to slash its price target, also cutting the EV maker's stock to hold from buy.
Stocks falling:
Regions Financial Corp.'s stock (RF) was down more than 3% in afternoon trading. The regional bank reported a profit rise for the first quarter as deposits remained stable despite the recent banking crisis, but it missed its earnings target.
Shares of Meta Platforms Inc.(META) were off 0.5% and on track for their fifth-straight session of declines after Chief Executive Mark Zuckerberg reportedly said the tech company may not be through laying off workers, as its latest round of 4,000 landed this week and another batch looms for May.
Shares of W.R. Berkley Corp.(WRB) were leading S&P 500 losers Friday, off nearly 10%. The insurer came up short of Wall Street's profit expectations.
Schlumberger Ltd.'s stock (SLB) was slumping 5%. The oil-field services company reported first-quarter adjusted earnings per share and revenue that beat forecasts, but cash flow from operations came in below consensus.
Shares of Autoliv Inc. (ALIV-SDB.SK) were shedding nearly 6% after the automotive safety-systems company reported first-quarter revenue that topped expectations and profit that matched, but said cash flow turned negative.
BuzzFeed Inc. shares (BZFD) were falling 9%, extending severe declines seen Thursday when the announced job cuts and the closing of its news arm
BlackRock Inc. shares (BLK) were down 2% in Friday afternoon action after Chief Executive Larry Fink dumped $25 million in stock, according to a recent filing.
-Barbara Kollmeyer
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-21-23 1333ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track